Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 81
Filter
1.
Cureus ; 15(9): e45271, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37846253

ABSTRACT

Non-bacterial thrombotic endocarditis (NBTE) involves the deposition of fibrin and platelets on heart valves, frequently leading to systemic embolism. The association between NBTE and cancer demands thorough investigation in cases lacking an evident cause. This case report elucidates the clinical course of a nonsmoking woman in her sixties with NBTE linked to pulmonary adenocarcinoma. The patient, who had a history of multiple sclerosis (MS) and was receiving dimethyl fumarate treatment, presented to the emergency department with stroke-like symptoms. Diagnostic challenges arose due to preexisting motor sensory impairment from MS. Initial evaluations revealed hypocapnia and elevated inflammatory markers. Blood cultures were obtained twice, and imaging confirmed pneumonia, left pleural effusion, and chronic pulmonary embolism while excluding acute vascular events or intracranial hemorrhage. The first transthoracic echocardiogram (TTE) indicated no cardiac abnormalities. Treatment encompassed parenteral antibiotics, systemic anticoagulation, and admission to medical floors. Although the initial treatment yielded a positive clinical response, subsequent complications emerged. On the tenth day, the patient required additional interventions, including broad-spectrum antibiotics and supplemental oxygen. A follow-up chest X-ray revealed persistent pneumonia and pleural effusion, and blood cultures upon admission returned negative. A subsequent head MRI confirmed an embolic stroke and displayed evidence of MS progression. Around the twentieth day, empirical treatment for infective endocarditis was initiated, and an 8 mm vegetation on the aortic valve was identified via transesophageal echocardiography (TOE). Acute pulmonary edema prompted a transfer to the intermediate care unit. Further investigations, including left thoracocentesis and CT, unveiled exudate and metastatic lesions in the liver, ilium, and kidney. Unfortunately, on the twenty-fifth day, the patient experienced acute myocardial infarction, right leg ischemia, disseminated intravascular coagulation, and shock. Pleural fluid analysis revealed malignant cells suggestive of lung adenocarcinoma. This case underscores the pivotal role of timely NBTE recognition and the search for malignancy when workup for infective endocarditis and autoimmune panels is negative. Moreover, it emphasizes the significance of vigilant monitoring, particularly in immunocompromised individuals or those with preexisting neurological deficits, especially when new neurological symptoms manifest. These insights significantly contribute to the comprehension of NBTE management and its implications for analogous patient cohorts.

2.
Bull Environ Contam Toxicol ; 109(3): 436-442, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35871684

ABSTRACT

We evaluated feathers as a non-destructive biomonitoring tool documenting organochlorine pesticides (OCP) in liver and checked possible trends in pesticide use in two areas based on OCP concentrations in barn owls (Tyto alba). We measured the concentrations of 16 OCP in 15 primary feathers and 15 livers from barn owl carcasses collected on roadsides in Tagus Valley and Évora regions, south Portugal. Total OCP mean concentration was 8 120 ng g-1 in feathers and 178 ng g-1 in livers. All compounds were detected in feathers while in livers δ-HCH, endosulfan sulphate, p,p'-DDT and p,p'-DDD were not detected. The high ß-HCH and heptachlor concentrations in feathers most likely derived from external endogenous contamination. P,p'-DDE was the OCP with the highest hepatic concentration. Both matrices indicated an exposure to recently released heptachlor. The differing OCP concentrations between Tagus Valley and Évora seem to reflect differences in land-use and pesticide use histories of the two locations, and/or faster degradation of OCP in the Tagus area.


Subject(s)
Hydrocarbons, Chlorinated , Pesticides , Strigiformes , Animals , DDT , Dichlorodiphenyl Dichloroethylene , Environmental Monitoring , Feathers/chemistry , Heptachlor , Hydrocarbons, Chlorinated/analysis , Liver/metabolism , Pesticides/analysis , Portugal , Strigiformes/metabolism
3.
Clin Oncol (R Coll Radiol) ; 34(9): e410-e419, 2022 09.
Article in English | MEDLINE | ID: mdl-35717318

ABSTRACT

AIMS: The aim of TROG 14.04 was to assess the feasibility of deep inspiration breath hold (DIBH) and its impact on radiation dose to the heart in patients with left-sided breast cancer undergoing radiotherapy. Secondary end points pertained to patient anxiety and cost of delivering a DIBH programme. MATERIALS AND METHODS: The study comprised two groups - left-sided breast cancer patients engaging DIBH and right-sided breast cancer patients using free breathing through radiotherapy. The primary end point was the feasibility of DIBH, defined as left-sided breast cancer patients' ability to breath hold for 15 s, decrease in heart dose in DIBH compared with the free breathing treatment plan and reproducibility of radiotherapy delivery using mid-lung distance (MLD) assessed on electronic portal imaging as the surrogate. The time required for treatment delivery, patient-reported outcomes and resource requirement were compared between the groups. RESULTS: Between February and November 2018, 32 left-sided and 30 right-sided breast cancer patients from six radiotherapy centres were enrolled. Two left-sided breast cancer patients did not undergo DIBH (one treated in free breathing as per investigator choice, one withdrawn). The mean heart dose was reduced from 2.8 Gy (free breathing) to 1.5 Gy (DIBH). Set-up reproducibility in the first week of treatment assessed by MLD was 1.88 ± 1.04 mm (average ± 1 standard deviation) for DIBH and 1.59 ± 0.93 mm for free breathing patients. Using a reproducibility cut-off for MLD of 2 mm (1 standard deviation) as per study protocol, DIBH was feasible for 67% of DIBH patients. Radiotherapy delivery using DIBH took about 2 min longer than for free breathing. Anxiety was not significantly different in DIBH patients and decreased over the course of treatment in both groups. CONCLUSION: Although DIBH was shown to require about 2 min longer per treatment slot, it has the potential to reduce heart dose in left-sided breast cancer patients by nearly a half, provided careful assessment of breath hold reproducibility is carried out.


Subject(s)
Breast Neoplasms , Unilateral Breast Neoplasms , Breast Neoplasms/radiotherapy , Breath Holding , Feasibility Studies , Female , Heart , Humans , Organs at Risk , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/methods , Reproducibility of Results , Unilateral Breast Neoplasms/radiotherapy
4.
J Hum Nutr Diet ; 33(6): 811-821, 2020 12.
Article in English | MEDLINE | ID: mdl-32609428

ABSTRACT

BACKGROUND: Computed tomography (CT) is the gold standard of body composition analysis at the tissue-organ level. The present study aimed to determine the impact of CT-defined sarcopenia and myosteatosis on outcomes, including overall survival, unplanned hospital admissions and related costs, in patients who had completed treatment of curative intent for head and neck cancer (HNC). METHODS: Retrospective observational study of patients undergoing radiotherapy of curative intent ± other treatment modalities for HNC. Tissue density data derived at the third lumbar vertebra (L3) were evaluated with sarcopenia defined per sex-specific published threshold values for skeletal muscle index, stratified by body mass index and mean skeletal muscle attenuation in HU (Hounsfield units). RESULTS: Pre- or post-treatment images were available for 79/98 patients (80.6%) and 61/98 patients (62.2%), respectively. Sarcopenia was present in 42/79 patients pre-treatment and 36/61 patients post-treatment, whereas myosteatosis was present in 63/79 patients pre-treatment and 48/61 patients post-treatment. In patients with pre- and post-treatment images (n = 60), the median (range) percentage weight change was -8.5% (-29.9 to +11.7). On multivariable analysis, a post-treatment sarcopenia hazard ratio of 3.87 (95% confidence interval = 1.22-12.24, P = 0.021) and a pre-treatment myosteatosis hazard ratio of 8.86 (95% confidence interval = 1.12-69.88, P = 0.038) were independent predictors of reduced overall survival. There was no difference in radiotherapy or chemotherapy treatment completion based on pre-treatment sarcopenia status. The mean (SD) difference unplanned hospital admission cost was $15 846 ($17 707) for patients without sarcopenia versus $47 945 ($82 688) for patients with sarcopenia at any time point (P = 0.077). CONCLUSIONS: As CT-defined sarcopenia and myosteatosis hold clinically meaningful prognostic value, muscle status evaluation is recommended in routine clinical practice.


Subject(s)
Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/radiotherapy , Muscular Diseases/mortality , Radiation Injuries/mortality , Sarcopenia/mortality , Body Composition , Female , Head and Neck Neoplasms/complications , Health Care Costs/statistics & numerical data , Humans , Lumbar Vertebrae/diagnostic imaging , Male , Middle Aged , Muscular Diseases/etiology , Muscular Diseases/physiopathology , Patient Admission/economics , Patient Admission/statistics & numerical data , Prognosis , Radiation Injuries/etiology , Radiation Injuries/physiopathology , Retrospective Studies , Sarcopenia/etiology , Sarcopenia/physiopathology , Tomography, X-Ray Computed , Treatment Outcome
5.
J Hum Nutr Diet ; 33(6): 862-868, 2020 12.
Article in English | MEDLINE | ID: mdl-32378264

ABSTRACT

BACKGROUND: Different nutritional screening instruments can be used to identify the risk of malnutrition in advanced chronic liver disease patients. The present study aimed to evaluate and compare two nutrition screening tools with the Global Leadership Initiative on Malnutrition (GLIM) diagnostic criteria for malnutrition in patients with advanced chronic liver disease. METHODS: Two nutritional screening tools, Nutritional Risk Screening 2002 (NRS-2002) and Royal Free Hospital Nutritional Prioritizing Tool (RFH-NPT), were assessed for 166 patients with liver cirrhosis. We compared medium/high nutritional risk screening with the diagnosis of malnutrition, using the GLIM criteria as the reference standard. RESULTS: According to the GLIM criteria, 57.3% of the patients were malnourished. NRS and RFH-NPT identified, respectively, 36.1% and 52.4% of patients with nutritional risk. RFH-NPT presented better agreement with the diagnosis according to GLIM criteria (k = 0.64; 95% confidence interval = 0.52-0.75), higher sensitivity (80%), higher negative predictive value (79%) and larger area under the curve (82.3%) compared to the NRS. CONCLUSIONS: RFH-NPT, when compared with the GLIM method, has substantial agreement in identifying nutritional risk, good sensitivity and good value for diagnosing malnutrition in patients with advanced chronic liver disease.


Subject(s)
End Stage Liver Disease/classification , Malnutrition/diagnosis , Mass Screening/methods , Nutrition Assessment , Risk Assessment/methods , Aged , Cross-Sectional Studies , End Stage Liver Disease/complications , End Stage Liver Disease/physiopathology , Female , Humans , Male , Malnutrition/etiology , Middle Aged , Nutritional Status , Severity of Illness Index
7.
Crit Rev Oncol Hematol ; 120: 60-76, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29198339

ABSTRACT

BACKGROUND: Childhood cancer survival is increasing. But cancer and treatment late-effects can lead to ongoing health care use. We summarised the literature on the patterns and drivers of health care use among childhood cancer survivors. METHOD: Pubmed, Embase and Medline were searched for studies reporting health care use in childhood cancer survivors. RESULTS: We included 22 studies, covering 88787 experiences of health care use. The proportion of survivors using follow-up care, physician visits, specialist visits, hospitalisations, dental care and screening services varied (36.4%-88.8%). Participation in screening was below recommendations (11.5%-81%). Drivers of increased health care use included higher income, private health insurance, attending follow-up care, chronic health conditions, prior radiotherapy, being female and older age. CONCLUSION: Sociodemographic and clinical factors result in differences in health care use. Future research could investigate whether such use is appropriate and how survivors might be engaged to receive care appropriate to manage their needs.


Subject(s)
Aftercare/statistics & numerical data , Cancer Survivors/statistics & numerical data , Neoplasms/therapy , Humans
8.
Pediatr Blood Cancer ; 64(1): 163-171, 2017 01.
Article in English | MEDLINE | ID: mdl-27442621

ABSTRACT

BACKGROUND: Grandparents can play a crucial role of providing emotional and practical support for families facing childhood cancer. Yet, many have their own healthcare needs. This controlled study systematically assesses the impact of childhood cancer on grandparents' quality of life (QOL). Our objective was to compare QOL in grandparents of children with and without cancer and to identify factors associated with grandparents' QOL. PROCEDURE: Grandparents (N = 222) completed two patient-reported outcome (PRO) measures assessing QOL: EQ-5D-5L and WHOQOL-BREF. Secondary endpoints included sleep, medications and hospitalizations. We used independent samples t-tests and multivariate linear regression to assess between-group differences and identify predictors. RESULTS: Grandparents of children with cancer (n = 89) reported significantly worse QOL than controls (n = 133) [mean WHOQOL-BREF score: 75.6 (SD = 17.6) vs. 81.5 (15.6), P = 0.007; mean EQ-5D-5L index value: 0.777 (0.20) vs. 0.874 (0.14), P < 0.001)]. They also reported more problems with anxiety and depression (47.2 vs. 21.8%, P < 0.001) and pain (64.8 vs. 49.6%, P = 0.031). Grandparents of children with cancer reported taking longer to fall asleep [mean: 30.4 min (55.6) vs. 18.2 (20.2), P = 0.011] and taking more medications in the last 4 weeks [mean: 2.9 (SD = 3.8) vs. 1.8 (SD = 2.3), P = 0.012]. Hospitalizations were comparable across groups. Grandmothers, those living in urban locations, and retired/unemployed grandparents experienced reduced QOL. CONCLUSIONS: Grandparents are significantly affected by childhood cancer. The impact appears across many domains of life and results in meaningful QOL differences. Given that four or more individuals may be affected per child, and that grandparent well-being can influence the whole family, interventions targeting at-risk grandparents are needed.


Subject(s)
Grandparents/psychology , Hospitalization/statistics & numerical data , Medication Adherence/psychology , Neoplasms/therapy , Quality of Life , Adolescent , Adult , Aged , Aged, 80 and over , Anxiety/epidemiology , Australia/epidemiology , Child , Child, Preschool , Combined Modality Therapy , Depression/epidemiology , Family , Female , Follow-Up Studies , Humans , Infant , Male , Middle Aged , Neoplasms/psychology , Prevalence , Prognosis , Surveys and Questionnaires , Young Adult
10.
J Hum Hypertens ; 29(8): 488-94, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25518896

ABSTRACT

Systolic hypertension is associated with cognitive decline in the elderly. Altered blood pressure (BP) variability is a possible mechanism of reduced cognitive performance in elderly hypertensives. We hypothesized that altered beat-to-beat systolic BP variability is associated with reduced global cognitive performance in elderly hypertensive subjects. In exploratory analyses, we also studied the correlation between diverse discrete cognitive domains and indices of systolic BP and heart rate variability. Disproving our initial hypothesis, we have shown that hypertension and low education, but not indices of systolic BP and heart rate variability, were independent predictors of lower global cognitive performance. However, exploratory analyses showed that the systolic BP variability in semi-upright position was an independent predictor of matrix reasoning (B = 0.08 ± .03, P-value = 0.005), whereas heart rate variability in semi-upright position was an independent predictor of the executive function score (B = -6.36 ± 2.55, P-value = 0.02). We conclude that myogenic vascular and sympathetic modulation of systolic BP do not contribute to reduced global cognitive performance in treated hypertensive subjects. Nevertheless, our results suggest that both systolic BP and heart rate variability might be associated with modulation of frontal lobe cognitive domains, such as executive function and matrix reasoning.


Subject(s)
Blood Pressure/physiology , Cognition/physiology , Heart Rate/physiology , Hypertension/physiopathology , Hypertension/psychology , Aged , Female , Humans , Male , Middle Aged , Posture
11.
Occup Med (Lond) ; 63(8): 556-62, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24253807

ABSTRACT

BACKGROUND: Occupation is recognized as a modifiable factor related to cognitive reserve in older adults. AIMS: To examine the association between levels of complexity in lifelong occupations and cognitive performance in later life. METHODS: A cross-sectional study of older adult users (aged 65 or more) of a private health care plan, resident in the north zone of Rio de Janeiro City, Brazil, and participating in the Rio de Janeiro section of the Study of Fragility in Brazilian Older Adults (FIBRA-RJ). Cognitive performance scores were obtained using the Mini-Mental State Examination. The level of complexity of their work was assessed in three domains: work with data, persons and things. Associations between the complexity of work in each domain and cognitive performance were evaluated using multivariate linear regression, adjusted for socio-demographic variables and duration of occupation. RESULTS: A total of 624 older adults (94% of the study group) performed lifelong work activities. Among those working with data, the high complexity group had cognitive performance scores 1.08 points higher (P < 0.05) than low complexity. In work with things, scores in the intermediate complexity group were 0.53 points higher (P < 0.05) than low complexity. There was no statistically significant difference in the cognitive performance between levels of complexity of work with people. CONCLUSIONS: Complexity in work with data and things was associated with better cognitive performance in later life, independent of age, schooling, income and duration of occupation.


Subject(s)
Cognition Disorders/psychology , Cognition/physiology , Occupations , Age Factors , Aged , Aged, 80 and over , Brazil , Cross-Sectional Studies , Female , Humans , Male , Neuropsychological Tests , Socioeconomic Factors
12.
J Toxicol Environ Health A ; 75(16-17): 1000-11, 2012.
Article in English | MEDLINE | ID: mdl-22852850

ABSTRACT

Chrysin is one of the natural flavonoids present in plants, and large amounts are present in honey and propolis. In addition to anticancer, antioxidation, and anti-inflammatory activities, chrysin has also been reported to be an inhibitor of aromatase, an enzyme converting testosterone into estrogen. The present study evaluated the mutagenicity of this flavonoid using micronucleus (MN) with HepG2 cells and Salmonella. Cell survival after exposure to different concentrations of chrysin was also determined using sulforhodamine B (SRB) colorimetric assay in HepG2 cells and the influence of this flavonoid on growth of cells in relation to the cell cycle and apoptosis. The MN test showed that from 1 to 15 µM of this flavonoid mutagenic activity was noted in HepG2 cells. The Salmonella assay demonstrated a positive response to the TA100 Salmonella strain in the presence or absence of S9, suggesting that this compound acted on DNA, inducing base pair substitution before or after metabolism via cytochrome P-450. The SRB assay illustrated that chrysin promoted growth inhibition of HepG2 cells in both periods studied (24 and 48 h). After 24 h of exposure it was noted that the most significant results were obtained with a concentration of 50 µM, resulting in 83% inhibition and SubG0 percentage of 12%. After 48 h of incubation cell proliferation inhibition rates (97% at 50 µM) were significantly higher. Our results showed that chrysin is a mutagenic and cytotoxic compound in cultured human HepG2 cells and Salmonella typhimurium. Although it is widely accepted that flavonoids are substances beneficial to health, one must evaluate the risk versus benefit relationship and concentrations of these substances to which an individual may be exposed.


Subject(s)
Aromatase Inhibitors/pharmacology , Flavonoids/pharmacology , Salmonella/drug effects , Cell Cycle , Cell Proliferation/drug effects , Estradiol/chemistry , Estradiol/metabolism , Hep G2 Cells , Hepatocytes/drug effects , Hepatocytes/enzymology , Humans , Micronucleus Tests , Molecular Structure , Mutagenesis , Testosterone/chemistry , Testosterone/metabolism
13.
Support Care Cancer ; 12(6): 463-6, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15088136

ABSTRACT

GOALS OF WORK: We set out to assess the preference of patients with common cancers involving bone receiving intravenous bisphosphonate therapy for either pamidronate (P) or zoledronic acid (Z) and their preference for the location of the infusion (clinic or home). We also aimed to monitor these patients' renal safety, and to compare their time in clinic to receive P and Z infusions. PATIENTS AND METHODS: Enrolled in the study were 184 patients, and all received initial infusions of Z (so any first infusion reactions did not confound preferences for P). For their second and third infusions, patients were randomized to receive Z then P or P then Z, and questioned on their preferences. For up to 1 year they continued on Z infusions every 3-4 weeks, while their renal safety was monitored. Where practical, later infusions were given at home (rather than in the clinic) and patients questioned on their preferred infusion location. In a convenience subset of 43 patients, clinic use for Z and P infusions was also measured by timing infusions and other procedures. MAIN RESULTS: Of 144 patients who received a third infusion, 138 responded to questions on bisphosphonate preference, and of these 138, 92% (127) preferred Z to P, because shorter infusions caused less disruption to their day. Only 12% of eligible patients (16/138) received home infusions, but 13/14 questioned preferred this location. Among 184 patients, 19 episodes of renal impairment were noted, mostly owing to disease progression (e.g. obstructive uropathy), with none linked to Z therapy. The mean clinic time taken to receive Z and any concomitant therapy was about half that for P (78 vs 161 min). CONCLUSIONS: Cancer patients prefer shorter bisphosphonate infusions-and at home, where practical. Regular Z 4 mg infusions appear to be safe in these patients, with routine monitoring of serum creatinine. Using Z rather than P could save busy cancer centres time and improve patient satisfaction.


Subject(s)
Antineoplastic Agents/administration & dosage , Bone Neoplasms/drug therapy , Diphosphonates/administration & dosage , Imidazoles/administration & dosage , Patient Satisfaction , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/adverse effects , Confidence Intervals , Diphosphonates/adverse effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Humans , Imidazoles/adverse effects , Infusions, Intravenous , Male , Middle Aged , Outpatients/psychology , Pamidronate , Quality of Life , Surveys and Questionnaires , Time Factors , Treatment Outcome , Zoledronic Acid
14.
Nutr. hosp ; 17(6): 262-270, nov. 2002. tab, graf
Article in En | IBECS | ID: ibc-16749

ABSTRACT

Taurine, a sulphur containing amino acid, is the most abundant intracellular amino acid in humans, and is implicated in numerous biological and physiological functions. This comprehensive overview explores areas, from its characterisation to its potential clinical benefit as a conditionally essential amino acid and a pharmaconutrient. In healthy individuals the diet is the usual source of taurine; although in the presence of vitamin B6 it is also synthesised from methionine and cysteine. Taurine has a unique chemical structure that implies important physiological functions: bile acid conjugation and cholestasis prevention, antiarrhythmic/inotropic/chronotropic effects, central nervous system neuromodulation, retinal development and function, endocrine/metabolic effects and antioxidant/antiinflammatory properties. Taurine is an essential amino acid for preterm neonates and is assured by breast milk. Specific groups of individuals are at risk for taurine deficiency and may benefit from supplementation, e. g. patients requiring long-term parenteral nutrition (including premature and newborn infants); those with chronic hepatic, heart or renal failure. Further studies are required to determine the benefits of replenishing taurine pools as well as the need to include taurine routinely in parenteral nutrition regimens (AU)


La taurina, un aminoácido que contiene azufre, es el aminoácido intracelular más abundante del ser humano e interviene en numerosas funciones biológicas y fisiológicas. En esta amplia revisión se exploran distintos campos, desde su caracterización hasta su posible utilidad clínica como aminoácido circunstancialmente esencial y como fármaconutriente. La dieta de las personas sanas es la fuente habitual de taurina; no obstante, en presencia de vitamina B6, también se sintetiza a partir de la metionina y de la cisteína. La taurina posee una estructura química singular que facilita funciones fisiológicas importantísimas: conjugación de los ácidos biliares y evitación de colestasis, efectos antiarrítmicos/inotropos/cronotropos, neuromodulación del sistema nervioso central, desarrollo y función de la retina, efectos endocrinometabólicos y propiedades antioxidantes/antiinflamatorias. La taurina es un aminoácido esencial para los prematuros y su presencia queda asegurada con la leche materna. Algunos grupos concretos de personas corren riesgo de sufrir carencia de taurina y pueden mejorar con los suplementos, por ejemplo, los pacientes que precisan nutrición parenteral prolongada (incluidos los prematuros y recién nacidos), los enfermos con hepatopatía crónica, insuficiencia cardíaca crónica o insuficiencia renal. Se requieren nuevos estudios para conocer las ventajas derivadas del llenado de los depósitos de taurina así como de la necesidad de incluir la taurina de forma sistemática en los tratamientos de nutrición parenteral (AU)


Subject(s)
Infant, Newborn , Humans , Taurine , Parenteral Nutrition , Amino Acids, Essential
15.
Nutr Hosp ; 17(6): 262-70, 2002.
Article in English | MEDLINE | ID: mdl-12514918

ABSTRACT

Taurine, a sulphur containing amino acid, is the most abundant intracellular amino acid in humans, and is implicated in numerous biological and physiological functions. This comprehensive overview explores areas, from its characterisation to its potential clinical benefit as a conditionally essential amino acid and a pharmaconutrient. In healthy individuals the diet is the usual source of taurine; although in the presence of vitamin B6 it is also synthesised from methionine and cysteine. Taurine has a unique chemical structure that implies important physiological functions: bile acid conjugation and cholestasis prevention, antiarrhythmic/inotropic/chronotropic effects, central nervous system neuromodulation, retinal development and function, endocrine/metabolic effects and antioxidant/antiinflammatory properties. Taurine is an essential amino acid for preterm neonates and is assured by breast milk. Specific groups of individuals are at risk for taurine deficiency and may benefit from supplementation, e.g. patients requiring long-term parenteral nutrition (including premature and newborn infants); those with chronic hepatic, heart or renal failure. Further studies are required to determine the benefits of replenishing taurine pools as well as the need to include taurine routinely in parenteral nutrition regimens.


Subject(s)
Amino Acids, Essential/physiology , Taurine/physiology , Humans , Infant, Newborn , Parenteral Nutrition , Taurine/deficiency
16.
Pesqui Odontol Bras ; 15(3): 223-8, 2001.
Article in Portuguese | MEDLINE | ID: mdl-11705270

ABSTRACT

The present study evaluated the effect of low doses of electron radiation on the activity of phosphodiesterases in granulation tissue. In order to induce growth of granulation tissue, a PVC sponge disk was introduced under the dorsal skin of 84 Wistar rats. The rats were divided in two groups, control and irradiated. The enzymatic activity was evaluated according to the evolution of the granulation tissue after 5, 7, 10, 14, 17, 20 and 24 days. Irradiation was carried out 3 days after the implantation of the sponge, by means of a linear accelerator, with energy of 6 MeV, and dose of 1.0 Gy. The results of this study showed that 5'-nucleotidase and ATPase had their activity directly affected by irradiation only in the beginning of the tissue repairing process. Alkaline phosphatase did not suffer any direct effect of irradiation. It is possible that the main factor has been the damage of the cellular components responsible for the growth of granulation tissue, which determine the production of enzymes according to the necessity.


Subject(s)
Beta Particles , Granulation Tissue/enzymology , Granulation Tissue/radiation effects , Phosphoric Diester Hydrolases/metabolism , Animals , Male , Rats , Rats, Wistar
17.
Clin Nutr ; 20(2): 187-93, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11327750

ABSTRACT

UNLABELLED: Enteral nutrition support via a feeding tube is the first choice for artificial nutrition. Most patients also require simultaneous drug therapy, with the potential risk for drug-nutrient interactions which may become relevant in clinical practice. During enteral nutrition, drug-nutrient interactions are more likely to occur than in patients fed orally. However, there is a lack of awareness about its clinical significance, which should be recognised and prevented in order to optimise nutritional and pharmacological therapeutic goals of safety and efficacy. LEARNING OBJECTIVES: To raise the awareness of potential drug-nutrient interactions and influence on clinical outcomes. To identify factors that can promote drug-nutrient interactions and contribute to nutrition and/or therapeutic failure. To be aware of different types of drug-nutrient interactions. To understand complex underlying mechanisms responsible for drug-nutrient interactions. To learn basic rules for the administration of medications during tube-feeding.


Subject(s)
Enteral Nutrition , Food-Drug Interactions , Intestinal Absorption/drug effects , Education, Continuing , Humans , Pharmacokinetics , Risk Factors , Treatment Outcome
18.
Clin Nutr ; 20(1): 31-6, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11161541

ABSTRACT

AIMS: This prospective, controlled, randomized crossover trial was conducted to assess the effects of parenteral nutrition, with or without lipids, in cyclosporine (CyA) pharmacokinetics. METHODS: 10 adult patients were randomized on the day of allogeneic bone marrow transplantation to receive isocaloric and isonitrogenous parenteral nutrition admixtures without (regimen A) or with lipids (regimen B). Admixtures were started on average by day + 7.4; 5 patients received regimen A followed by B, 5 in reverse order. Blood samples were collected at day 4 after transplantation, under oral diet, and 4 days after the initiation of each regimen as the sole nutrition support. At each time point, 8 whole blood samples were analysed for CyA to evaluate: area under the curve (AUC), trough concentration and systemic clearance. Clinical/laboratory events were recorded until 31 months of follow-up. RESULTS: There was no evidence of a period or treatment-by period interaction, thus results were combined for further analysis. There were no statistically significant differences between regimens in any CyA pharmacokinetic parameters; there were no significant differences from baseline values, except for a higher systemic clearance of CyA with regimen A (0.40+/-0.09 vs 0.29+/-0.06 L/Kg/h, p=0.03). CONCLUSIONS: The provision of 0.8 g/Kg/d of a 50:50 mixture of medium and long chain triglycerides did not affect CyA parameters, which were closer to baseline. In the short or long term there were no attributable side effects.


Subject(s)
Bone Marrow Transplantation , Cyclosporine/pharmacokinetics , Fat Emulsions, Intravenous/administration & dosage , Immunosuppressive Agents/pharmacokinetics , Parenteral Nutrition , Adult , Area Under Curve , Cross-Over Studies , Cyclosporine/blood , Fat Emulsions, Intravenous/pharmacology , Female , Humans , Male , Middle Aged , Prospective Studies
19.
Catheter Cardiovasc Interv ; 50(4): 413-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10931611

ABSTRACT

The aim of this study was to evaluate long-term clinical follow-up and echocardiographic data on pregnant patients with mitral stenosis who underwent percutaneous mitral valvuloplasty (PMV) in our center and the development of their infants. PMV has proven to be an effective alternative to treat pregnant patients with mitral stenosis. However, long-term outcome of these patients, as well as the potential harmful effects caused by radiation on their infants, still awaits to be determined. From January 1988 to February 1999, 30 pregnant women (mean gestational duration, 24.95 +/- 5.59 weeks) underwent PMV. Twenty-three (77%) were subsequently followed by a medical interview during 5.33 +/- 3.12 years. Clinical variables such as NYHA functional class (FC), the need of a repeat PMV or surgical procedure, the presence of embolic events, and mortality rate were evaluated during follow-up. Mitral valve area, mean transmitral gradient, and the presence of mitral regurgitation were also assessed by Doppler echocardiography. Clinical data on the development of the infants were obtained from the assistant pediatricians. All patients were in NYHA FC III or IV before the procedure. During follow-up, 91% of them were in FC I and II. Two patients (9%) who had remained in FC III underwent a repeat successful PMV; no further surgery was required. There were no embolic events or death related to the procedure. Echocardiography showed an initial increase in mitral valve area from 1.14 +/- 0.22 cm(2) to 2.01 +/- 0.21 cm+/- (P < 0.0001). During long-term follow-up, it decreased to a mean of 1.75 +/- 0.24 cm(2) (P < 0. 0001). Initial transmitral valve gradient decreased from 17.73 +/- 4. 56 mm Hg to 5.91 +/- 1.80 mm Hg (P = 0.0001) and 8.95 +/- 3.58 (P = 0.002) during long-term follow-up. Twenty one children (96%), aged 4. 91 +/- 2.8 years, showed normal growth and development, and no clinical abnormalities were observed. These favorable long-term results suggests PVM to be the procedure of choice to treat pregnant women with mitral stenosis who remain in FC III or IV despite adequate medical therapy. No harmful effects due to the use of radiation were observed in the children.


Subject(s)
Catheterization , Mitral Valve Stenosis/therapy , Pregnancy Complications, Cardiovascular/therapy , Adolescent , Adult , Echocardiography, Doppler, Color , Female , Follow-Up Studies , Gestational Age , Hemodynamics , Humans , Infant, Newborn , Mitral Valve Stenosis/diagnostic imaging , Mitral Valve Stenosis/physiopathology , Pregnancy , Pregnancy Complications, Cardiovascular/diagnostic imaging , Pregnancy Complications, Cardiovascular/physiopathology , Pregnancy Outcome , Retrospective Studies
20.
Acta Med Port ; 13(4): 211-20, 2000.
Article in Portuguese | MEDLINE | ID: mdl-11155489

ABSTRACT

Magnesium is the second most abundant cation in intracellular fluid and is an essential electrolyte. It has several critically important roles in the body, namely as a cofactor in numerous enzyme systems, and is involved in phosphate transfer, muscle contractility and neuronal transmission. The physiologic role, homeostasis, causes and clinical manifestations of hypo and hypermagnesemia and their therapy are briefly reviewed. Magnesium treatment is emerging as an important adjunct in the management of a few conditions: prevention and control of seizures in eclampsia, cardiovascular diseases, diabetes mellitus, asthma and others.


Subject(s)
Homeostasis/physiology , Magnesium Deficiency/etiology , Magnesium/physiology , Humans , Magnesium/metabolism , Parenteral Nutrition, Total/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...